AKINETON Side Effects

5931627-3 | Neuroleptic Malignant Syndrome
on Oct 17, 2008 Male patient from UNITED KINGDOM , 50 years of age, was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome. Akineton dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), DROXIDOPA (View Droxidopa Review and Droxidopa Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ).

5928105-4 | Dependence
Patient was taking Akineton (View Usage). Patient had the following side effects: dependence on Oct 15, 2008 from ITALY Additional patient health information: Male patient , 60 years of age, was diagnosed with extrapyramidal disorder and. Akineton dosage: . During the same period patient was treated with FLUPHENAZINE (View Fluphenazine Review and Fluphenazine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

5921302-3 | Nervous System Disorder, Neuroleptic Malignant Syndrome
Adverse event was reported on Oct 08, 2008 by a Male patient taking Akineton (View Usage) (Dosage: ) . Location: JAPAN , 38 years of age, After Akineton was administered, patient had the following side effects: nervous system disorder, neuroleptic malignant syndrome.

5921242-X | Status Epilepticus
on Oct 09, 2008 Female patient from ITALY , 18 years of age, weighting 132.3 lb, was diagnosed with dystonia (What is dystonia?), cerebrovascular disorder and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: status epilepticus. Akineton dosage: 8-6-0 Mg, 1 In 2 Days. During the same period patient was treated with PREGABALIN (View Pregabalin Review and Pregabalin Label ), BACLOFEN (20-20-30mg, 1 In 3 Days) (View Baclofen Review and Baclofen Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ). Patient was hospitalized.


5920405-7 | Neuroleptic Malignant Syndrome
on Oct 09, 2008 Male patient from UNITED KINGDOM , 50 years of age, was treated with Akineton (View Usage). Patient had the following side effects: neuroleptic malignant syndrome. Akineton dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), DROXIDOPA (View Droxidopa Review and Droxidopa Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ).

5902003-4 | Status Epilepticus
Patient was taking Akineton (View Usage). After Akineton was administered, patient had the following side effects: status epilepticus on Sep 19, 2008 from ITALY Additional patient health information: Female patient , 18 years of age, weighting 132.3 lb, was diagnosed with dystonia (What is dystonia?), cerebrovascular disorder and. Akineton dosage: 8-6-0 Mg, 1 In 2 Days. During the same period patient was treated with PREGABALIN (View Pregabalin Review and Pregabalin Label ), BACLOFEN (20-20-30mg, 1 In 3 Days) (View Baclofen Review and Baclofen Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ). Patient was hospitalized.

5899091-0 | Anticholinergic Syndrome, Cognitive Disorder, Hallucination, Visual, Memory Impairment
Adverse event was reported on Sep 16, 2008 by a Male patient taking Akineton (View Usage) (Dosage: ) was diagnosed with schizophrenia, paranoid type, mental disorder and. Location: ITALY , 37 years of age, Patient experienced the following unwanted or unexpected effects: anticholinergic syndrome, cognitive disorder, hallucination, visual, memory impairment. During the same period patient was treated with CLOZAPINE (View Clozapine Review and Clozapine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ZUCLOPENTHIXOL (View Zuclopenthixol Review and Zuclopenthixol Label ).

5891998-3 | Status Epilepticus
on Sep 12, 2008 Female patient from ITALY , 18 years of age, weighting 132.3 lb, was diagnosed with dystonia (What is dystonia?) and was treated with Akineton (View Usage). Patient had the following side effects: status epilepticus. Akineton dosage: . During the same period patient was treated with PREGABALIN (View Pregabalin Review and Pregabalin Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ). Patient was hospitalized.

5889646-1 | Blood Creatine Phosphokinase Increased, Confusional State, Hypernatraemia, Metabolic Acidosis, Neuroleptic Malignant Syndrome, Pyrexia
on May 16, 2008 Female patient from ITALY , 64 years of age, was diagnosed with confusional state, alcohol detoxification, bipolar disorder (What is bipolar disorder?) and was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: blood creatine phosphokinase increased, confusional state, hypernatraemia, metabolic acidosis, neuroleptic malignant syndrome, pyrexia. Akineton dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), DISULFIRAM (View Disulfiram Review and Disulfiram Label ), CLOTIAPINE (View Clotiapine Review and Clotiapine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ). Patient was hospitalized.

5861009-4 | Dysphagia, Nuchal Rigidity, Paralysis
Patient was taking Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, nuchal rigidity, paralysis (What is paralysis?) on Aug 19, 2008 from BRAZIL Additional patient health information: Male patient , weighting 123.5 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), hypertension, blood pressure management and. Akineton dosage: . During the same period patient was treated with AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), VASERETIC (Form: 20/12.5 Milligrams) (View Vaseretic Review and Vaseretic Label ), MADOPAR (View Madopar Review and Madopar Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), CAPTOPRIL (View Captopril Review and Captopril Label ). Patient was hospitalized.

5860933-6 | Anticholinergic Syndrome, Cognitive Disorder, Hallucination, Visual, Memory Impairment
Adverse event was reported on Aug 05, 2008 by a Male patient taking Akineton (View Usage) (Dosage: ) was diagnosed with schizophrenia, paranoid type and. Location: ITALY , 37 years of age, Patient had the following side effects: anticholinergic syndrome, cognitive disorder, hallucination, visual, memory impairment. During the same period patient was treated with CLOZAPINE (View Clozapine Review and Clozapine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

5802382-2 | Disseminated Intravascular Coagulation, Multi-organ Failure, Neuroleptic Malignant Syndrome, Sepsis
on Jun 27, 2008 Female patient from JAPAN , 33 years of age, was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: disseminated intravascular coagulation, multi-organ failure, neuroleptic malignant syndrome, sepsis (What is sepsis?). Akineton dosage: .

5767924-4 | Palpitations
on Jun 05, 2008 Male patient from ARGENTINA , weighting 147.7 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), insomnia and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: palpitations. Akineton dosage: . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LEVODOPA (View Levodopa Review and Levodopa Label ).

5657350-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Dehydration, Labile Blood Pressure, Nausea, Neuroleptic Malignant Syndrome, Pyrexia, Rhabdomyolysis
Patient was taking Akineton (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dehydration, labile blood pressure, nausea (What is nausea?), neuroleptic malignant syndrome, pyrexia, rhabdomyolysis on Mar 03, 2008 from JAPAN Additional patient health information: Female patient , 72 years of age, weighting 88.18 lb, was diagnosed with depression (What is depression?) and. Akineton dosage: 3 Mg/day. During the same period patient was treated with BLOPRESS (4 Mg/day) (View Blopress Review and Blopress Label ), MEVALOTIN (10 Mg/day) (View Mevalotin Review and Mevalotin Label ), UBRETID (10 Mg/day) (View Ubretid Review and Ubretid Label ), DEPAS (0.5 Mg/day) (View Depas Review and Depas Label ), MAGNESIUM OXIDE (0.7 G/day) (View Magnesium Oxide Review and Magnesium Oxide Label ), ANAFRANIL (50 Mg/day) (View Anafranil Review and Anafranil Label ), SERENACE (5 Mg/day) (View Serenace Review and Serenace Label ), LUDIOMIL (25 Mg/tid) (View Ludiomil Review and Ludiomil Label ). Patient was hospitalized.

5650536-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Dehydration, Hepatic Function Abnormal, Labile Blood Pressure, Nausea, Neuroleptic Malignant Syndrome
Adverse event was reported on Feb 25, 2008 by a Female patient taking Akineton (View Usage) (Dosage: 3 Mg/day) was diagnosed with depression (What is depression?) and. Location: JAPAN , 72 years of age, weighting 88.18 lb, After Akineton was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, dehydration, hepatic function abnormal, labile blood pressure, nausea (What is nausea?), neuroleptic malignant syndrome. During the same period patient was treated with BLOPRESS (4 Mg/day) (View Blopress Review and Blopress Label ), MEVALOTIN (10 Mg/day) (View Mevalotin Review and Mevalotin Label ), UBRETID (10 Mg/day) (View Ubretid Review and Ubretid Label ), DEPAS (0.5 Mg/day) (View Depas Review and Depas Label ), MAGNESIUM OXIDE (0.7 G/day) (View Magnesium Oxide Review and Magnesium Oxide Label ), ANAFRANIL (50 Mg/day) (View Anafranil Review and Anafranil Label ), SERENACE (5 Mg/day) (View Serenace Review and Serenace Label ), LUDIOMIL (25 Mg/tid) (View Ludiomil Review and Ludiomil Label ). Patient was hospitalized.

5634979-7 | Palpitations
on Feb 12, 2008 Male patient from ARGENTINA , weighting 147.7 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), insomnia and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: palpitations. Akineton dosage: . During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LEVODOPA (View Levodopa Review and Levodopa Label ).

5537736-5 | Neuroleptic Malignant Syndrome
on Nov 29, 2007 Female patient from JAPAN , 51 years of age, was treated with Akineton (View Usage). Patient had the following side effects: neuroleptic malignant syndrome. Akineton dosage: .

5523941-0 | Delirium, Hallucination, Visual
Patient was taking Akineton (View Usage). After Akineton was administered, patient had the following side effects: delirium, hallucination, visual on Nov 15, 2007 from GERMANY Additional patient health information: Male patient , 65 years of age, was diagnosed with depression (What is depression?) and. Akineton dosage: . During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), LITHIUM SULFATE (View Lithium Sulfate Review and Lithium Sulfate Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

5520200-7 | Confusional State, Dysarthria, Nystagmus, Somnolence
Adverse event was reported on Nov 07, 2007 by a Male patient taking Akineton (View Usage) (Dosage: ) was diagnosed with extrapyramidal disorder, alcoholism (What is alcoholism?) and. Location: GREECE , 29 years of age, weighting 147.7 lb, Patient experienced the following unwanted or unexpected effects: confusional state, dysarthria, nystagmus, somnolence. During the same period patient was treated with CLOMETHIAZOLE EDISILATE (View Clomethiazole Edisilate Review and Clomethiazole Edisilate Label ), BUPRENORPHINE HYDROCHLORIDE (View Buprenorphine Hydrochloride Review and Buprenorphine Hydrochloride Label ), OXCARBAZEPINE (View Oxcarbazepine Review and Oxcarbazepine Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ).

5430091-0 | Hypotension, Overdose, Somnolence, Suicide Attempt, Tachycardia
on Aug 19, 2007 Female patient from GERMANY , 21 years of age, weighting 114.6 lb, was treated with Akineton (View Usage). Patient had the following side effects: hypotension, overdose, somnolence, suicide attempt, tachycardia. Akineton dosage: . During the same period patient was treated with ERGENYL TABLETS (View Ergenyl Tablets Review and Ergenyl Tablets Label ), EUNERPAN (View Eunerpan Review and Eunerpan Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ). Patient was hospitalized.

5328014-8 | Neuroleptic Malignant Syndrome
on May 07, 2007 Female patient from JAPAN , 43 years of age, was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: neuroleptic malignant syndrome. Akineton dosage: . During the same period patient was treated with PEROSPIRONE (View Perospirone Review and Perospirone Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ). Patient was hospitalized.

5316762-5 | Neuroleptic Malignant Syndrome
Patient was taking Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome on Apr 24, 2007 from JAPAN Additional patient health information: Female patient , 43 years of age, . Akineton dosage: . During the same period patient was treated with PEROSPIRONE (View Perospirone Review and Perospirone Label ), TRIHEXYPHENIDYL HYDROCHLORIDE (View Trihexyphenidyl Hydrochloride Review and Trihexyphenidyl Hydrochloride Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ). Patient was hospitalized.

5279496-1 | Neuroleptic Malignant Syndrome, Renal Failure Acute, Rhabdomyolysis
Adverse event was reported on Mar 19, 2007 by a Male patient taking Akineton (View Usage) (Dosage: ) was diagnosed with agitation and. Location: JAPAN , 37 years of age, Patient had the following side effects: neuroleptic malignant syndrome, renal failure acute, rhabdomyolysis. During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

5274986-X | Neuroleptic Malignant Syndrome, Renal Failure Acute, Rhabdomyolysis
on Mar 19, 2007 Male patient from JAPAN , 70 years of age, was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: neuroleptic malignant syndrome, renal failure acute, rhabdomyolysis. Akineton dosage: . During the same period patient was treated with SULPIRIDE (View Sulpiride Review and Sulpiride Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), CHLORPROMAZINE HYDROCHLORIDE (View Chlorpromazine Hydrochloride Review and Chlorpromazine Hydrochloride Label ), PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

5266168-2 | Neuroleptic Malignant Syndrome, Renal Failure Acute, Rhabdomyolysis
on Mar 07, 2007 Male patient from JAPAN , 70 years of age, was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome, renal failure acute, rhabdomyolysis. Akineton dosage: . During the same period patient was treated with SULPIRIDE (View Sulpiride Review and Sulpiride Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), CHLORPROMAZINE HYDROCHLORIDE (View Chlorpromazine Hydrochloride Review and Chlorpromazine Hydrochloride Label ), PROMETHAZINE HCL (View Promethazine Hcl Review and Promethazine Hcl Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

5198482-3 | Colitis Ischaemic, Colitis Ulcerative, Intestinal Gangrene, Intestinal Perforation, Pyrexia, Vomiting
Patient was taking Akineton (View Usage). Patient had the following side effects: colitis ischaemic, colitis ulcerative, intestinal gangrene, intestinal perforation, pyrexia, vomiting on Dec 29, 2006 from FRANCE Additional patient health information: Female patient , 47 years of age, . Akineton dosage: . During the same period patient was treated with LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), CLOMIPRAMINE HCL (View Clomipramine Hcl Review and Clomipramine Hcl Label ), TROPATEPINE (View Tropatepine Review and Tropatepine Label ).

5192334-0 | Colitis Ischaemic, Colitis Ulcerative, Colon Gangrene, Large Intestine Perforation, Megacolon, Pyrexia, Vomiting
Adverse event was reported on Dec 18, 2006 by a Female patient taking Akineton (View Usage) (Dosage: ) . Location: FRANCE , 47 years of age, After Akineton was administered, patient had the following side effects: colitis ischaemic, colitis ulcerative, colon gangrene, large intestine perforation, megacolon, pyrexia, vomiting. During the same period patient was treated with LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), CLOMIPRAMINE HCL (View Clomipramine Hcl Review and Clomipramine Hcl Label ), TROPATEPINE (View Tropatepine Review and Tropatepine Label ).

5153568-4 | Abnormal Behaviour, Cerebral Atrophy, Cognitive Disorder, Delirium, Disturbance In Attention, Memory Impairment
on Oct 17, 2006 Female patient from JAPAN , 77 years of age, was diagnosed with depression (What is depression?), dementia (What is dementia?) and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, cerebral atrophy, cognitive disorder, delirium, disturbance in attention, memory impairment. Akineton dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ). Patient was hospitalized.

5151084-7 | Delirium
on Oct 17, 2006 Female patient from JAPAN , 77 years of age, was diagnosed with depression (What is depression?), dementia (What is dementia?) and was treated with Akineton (View Usage). Patient had the following side effects: delirium. Akineton dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ). Patient was hospitalized.

5151058-6 | Delirium
Patient was taking Akineton (View Usage). After Akineton was administered, patient had the following side effects: delirium on Oct 17, 2006 from JAPAN Additional patient health information: Female patient , 77 years of age, was diagnosed with depression (What is depression?), dementia (What is dementia?) and. Akineton dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ). Patient was hospitalized.

5150963-4 | Delirium
Adverse event was reported on Oct 17, 2006 by a Female patient taking Akineton (View Usage) (Dosage: ) was diagnosed with depression (What is depression?), dementia (What is dementia?) and. Location: JAPAN , 77 years of age, Patient experienced the following unwanted or unexpected effects: delirium. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ). Patient was hospitalized.

5150674-5 | Delirium
on Oct 17, 2006 Female patient from JAPAN , 77 years of age, was diagnosed with depression (What is depression?), dementia (What is dementia?) and was treated with Akineton (View Usage). Patient had the following side effects: delirium. Akineton dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ). Patient was hospitalized.

5136639-8 | Abnormal Behaviour, Cognitive Disorder, Delirium
on Oct 17, 2006 Female patient from JAPAN , 77 years of age, was diagnosed with depression (What is depression?), dementia (What is dementia?) and was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: abnormal behaviour, cognitive disorder, delirium. Akineton dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ). Patient was hospitalized.

5133190-6 | Dystonia
Patient was taking Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?) on Aug 17, 2006 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with parkinsonism, dementia (What is dementia?) and. Akineton dosage: . During the same period patient was treated with LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), TIAPRIDE HYDROCHLORIDE (View Tiapride Hydrochloride Review and Tiapride Hydrochloride Label ). Patient was hospitalized.

5127902-5 | Hallucination
Adverse event was reported on Oct 06, 2006 by a Female patient taking Akineton (View Usage) (Dosage: ) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: SPAIN , 81 years of age, weighting 132.3 lb, Patient had the following side effects: hallucination.

5100165-2 | Dystonia
on Aug 17, 2006 Female patient from JAPAN , 75 years of age, was diagnosed with parkinsonism and was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: dystonia (What is dystonia?). Akineton dosage: . Patient was hospitalized.

5078397-1 | Convulsion, Urinary Retention
on Aug 01, 2006 Female patient from SPAIN , 76 years of age, was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, urinary retention. Akineton dosage: .

5006007-8 | Confusional State, Convulsion, Dry Mouth, Feeling Abnormal, Headache, Neurological Symptom
Patient was taking Akineton (View Usage). Patient had the following side effects: confusional state, convulsion, dry mouth, feeling abnormal, headache (What is headache?), neurological symptom on May 09, 2006 from SOUTH AFRICA Additional patient health information: Female patient , 46 years of age, was diagnosed with ventricular extrasystoles, arrhythmia supraventricular, blood oestrogen and. Akineton dosage: . During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ). Patient was hospitalized.

5005233-1 | Nephrotic Syndrome
Adverse event was reported on May 10, 2006 by a Female patient taking Akineton (View Usage) (Dosage: ) . Location: IRELAND , 50 years of age, After Akineton was administered, patient had the following side effects: nephrotic syndrome. Patient was hospitalized.

4952674-4 | Influenza Serology Positive, Neuroleptic Malignant Syndrome, Pyrexia, Renal Failure
on Mar 13, 2006 Male patient from JAPAN , 62 years of age, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: influenza serology positive, neuroleptic malignant syndrome, pyrexia, renal failure. Akineton dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), OSELTAMIVIR (View Oseltamivir Review and Oseltamivir Label ). Patient was hospitalized.

4885675-5 | Agitation, Confusional State, Delirium, Hallucination
on Jan 09, 2006 Male patient from AUSTRALIA , weighting 110.2 lb, was diagnosed with unevaluable event, oesophageal disorder, hypothyroidism and was treated with Akineton (View Usage). Patient had the following side effects: agitation, confusional state, delirium, hallucination. Akineton dosage: . During the same period patient was treated with SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), FEFOL (View Fefol Review and Fefol Label ), GABEXATE MESILATE (View Gabexate Mesilate Review and Gabexate Mesilate Label ), CEPHALEXIN MONOHYDRATE (View Cephalexin Monohydrate Review and Cephalexin Monohydrate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

4885672-X | Toxic Epidermal Necrolysis
Patient was taking Akineton (View Usage). After Akineton was administered, patient had the following side effects: toxic epidermal necrolysis on Jan 09, 2006 from AUSTRALIA Additional patient health information: Female patient , 17 years of age, was diagnosed with affective disorder and. Akineton dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), CHLORPROMAZINE HCL (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

4844199-1 | Asthenia
Adverse event was reported on Nov 23, 2005 by a Male patient taking Akineton (View Usage) (Dosage: ) was diagnosed with stress (What is stress?) and. Location: BRAZIL , 45 years of age, Patient experienced the following unwanted or unexpected effects: asthenia. During the same period patient was treated with CINNARIZINE (View Cinnarizine Review and Cinnarizine Label ), DIMETICONE (View Dimeticone Review and Dimeticone Label ). Patient was hospitalized.

4743023-5 | Asthenia, Dizziness, Fatigue
on Aug 04, 2005 Male patient from BRAZIL , 37 years of age, weighting 172.0 lb, was diagnosed with depression (What is depression?) and was treated with Akineton (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), fatigue. Akineton dosage: . Patient was hospitalized.

4694291-X | Foetal Heart Rate Abnormal, Macrosomia, Somnolence
on May 27, 2005 Female patient from , weighting 10.56 lb, was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: foetal heart rate abnormal, macrosomia, somnolence. Akineton dosage: . During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LITHIUM (View Lithium Review and Lithium Label ). Patient was hospitalized.

4683721-5 | Foetal Heart Rate Abnormal, Macrosomia, Somnolence
Patient was taking Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: foetal heart rate abnormal, macrosomia, somnolence on May 27, 2005 from Additional patient health information: Female patient , weighting 10.56 lb, . Akineton dosage: . Patient was hospitalized.

4666634-4 | Diarrhoea, Schizophrenia
Adverse event was reported on Apr 22, 2005 by a Male patient taking Akineton (View Usage) (Dosage: ) . Location: , weighting 176.4 lb, Patient had the following side effects: diarrhoea, schizophrenia. Patient was hospitalized.

4656464-1 | Coma, Overdose, Respiratory Depression, Suicide Attempt, Vomiting
on Apr 23, 2005 Female patient from , 51 years of age, weighting 187.4 lb, was diagnosed with suicide attempt and was treated with Akineton (View Usage). After Akineton was administered, patient had the following side effects: coma, overdose, respiratory depression, suicide attempt, vomiting. Akineton dosage: Per Oral. During the same period patient was treated with CARBAMAZEPINE (Per Oral) (View Carbamazepine Review and Carbamazepine Label ), BENPERIDOL (Per Oral) (View Benperidol Review and Benperidol Label ), TRUXAL DRAGEES (15 Mg, Per Oral) (View Truxal Dragees Review and Truxal Dragees Label ). Patient was hospitalized.

4656462-8 | Condition Aggravated, Diarrhoea, Schizophrenia
on Apr 22, 2005 Male patient from , 49 years of age, weighting 176.4 lb, was treated with Akineton (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, diarrhoea, schizophrenia. Akineton dosage: See Image. Patient was hospitalized.

4650389-3 | Diarrhoea, Schizophrenia
Patient was taking Akineton (View Usage). Patient had the following side effects: diarrhoea, schizophrenia on Apr 22, 2005 from Additional patient health information: Male patient , weighting 176.4 lb, . Akineton dosage: . Patient was hospitalized.